Topical Microbicides: Targeted Intracellular Delivery
Topical Microbicides: Targeted Intracellular Delivery
批准号:
8711813
负责人:
Peter A Anton
金额:
$59.83万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-03-01 至 2017-02-28
关键词:
AddressAdherenceAnatomyAnti-Retroviral AgentsAntibodiesAntiviral AgentsAutologousBehaviorBiological AvailabilityBlood CirculationBypassCellsClinical TrialsCoitusColorectalDataDiffusionDissociationDoseDrug Delivery SystemsDrug FormulationsDrug TargetingDrug usageEmploymentEncapsulatedGelHIVHIV-1HepatotoxicityHumanHydrogelsImmunologyIncidenceInfectionInflammatoryKidney FailureLactic AcidosisLocal MicrobicidesModificationMucositisMucous MembraneOralOral AdministrationPathogenesisPersonsPharmaceutical PreparationsPhasePolymer ChemistryPolymersPreventionPropertyProphylactic treatmentProteinsPublished CommentResearch PersonnelResistanceReverse Transcriptase InhibitorsRiskRouteScienceSiteTechnologyTenofovirTherapeuticTissuesToxic effectVaccinesVaginal GelViralVirusWaterWomanaqueousbasecell typedesigndosageemtricitabinehigh riskimmunogenicinterdisciplinary approachmen who have sex with menmicrobicidemucosal sitemultidisciplinarynanopolymernovelparticlepolypeptidepreventprophylacticprotein structurepublic health relevanceresponsesuccesstargeted deliverytheoriestransmission processuptake
中文摘要
描述(由申请人提供):该项目是对开发新型杀微生物剂以预防HIV-1感染的提案的响应。尽管有限的成功暗示了基于杀微生物剂的预防的前景,但临床试验的好坏参半的结果强调了简单凝胶方法的重大缺陷,这种方法依赖于间歇性应用和被动扩散来进行非特异性药物递送。我们已经组建了一个多学科的研究小组,以解决有效的杀微生物剂所需的主要问题:强效亲脂性药物的水递送、解剖定位、相关的细胞靶向、细胞内定位和应用后的持续活性。这些问题通过三个目标来解决,重点关注HIV-1获取的最高风险部位(结肠粘膜):目标1:具有可调特性的新型多肽水凝胶将适应于持续和粘附粘膜,以及捕获HIV-1颗粒。目标2:人类“vault”生物颗粒将被修饰为非极性抗逆转录病毒药物的载体,具有特异性靶向,将药物有效载荷在细胞浆内释放到相关细胞类型中。目标3:高分子化学将应用于加载
英文摘要
DESCRIPTION (provided by applicant): This project is a response to a call for proposals to develop novel microbicides to prevent HIV-1 infection. Although limited successes have hinted at the promise of microbicide-based prevention, the mixed results of clinical trials underscore the significant shortcomings of simple gel approaches, which depend on intermittent application and passive diffusion for nonspecific drug delivery. We have assembled a multidisciplinary team of investigators to address major issues required for an effective microbicide: aqueous delivery of potent lipophilic drugs, anatomic localization, relevant cell targeting, intracellular localizaton, and sustained activity after application. These issues are approached through three aims focused on the highest risk site of HIV-1 acquisition (the colorectal mucosa): Aim 1: Novel polypeptide hydrogels with tunable properties will be adapted to persist and adhere to mucosa, as well as capture HIV-1 particles. Aim 2: Human "vault" bioparticles will be modified as carriers for nonpolar antiretroviral drugs, with specific targeting to release the drug payload intracytoplasmically into relevant cell types. Aim 3: Polymer chemistry will be applied to load the
hydrogels with the vaults in a manner to provide sustained release and delivery of drugs into the relevant cell types for HIV-1 acquisition. These studies will provide a path to a safe, effective, and inexpensive microbicide for HIV-1 prevention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Topical Microbicides: Targeted Intracellular Delivery
-
批准号:8810224
-
项目类别:
-
资助金额:$58.15万
-
财政年份:2014
-
负责人:Peter A Anton
-
依托单位:
Mechanistic Studies of HIV-exposed Seronegative Individuals
-
批准号:8503631
-
项目类别:
-
资助金额:$36.17万
-
财政年份:2012
-
负责人:Peter A Anton
-
依托单位:
Data management and biostatistics
-
批准号:7979343
-
项目类别:
-
资助金额:$6.27万
-
财政年份:2009
-
负责人:Peter A Anton
-
依托单位:
Exploratory human trials of rectal microbicides
-
批准号:7979345
-
项目类别:
-
资助金额:$12.2万
-
财政年份:2009
-
负责人:Peter A Anton
-
依托单位:
Administrative
-
批准号:7979338
-
项目类别:
-
资助金额:$8.07万
-
财政年份:2009
-
负责人:Peter A Anton
-
依托单位:
Regulatory compliance and human subjects safety
-
批准号:7979340
-
项目类别:
-
资助金额:$9.16万
-
财政年份:2009
-
负责人:Peter A Anton
-
依托单位:
Mucosal Immunology Core
-
批准号:7480739
-
项目类别:
-
资助金额:$6.05万
-
财政年份:2008
-
负责人:Peter A Anton
-
依托单位:
Core A - Administrative
-
批准号:7127921
-
项目类别:
-
资助金额:$5.37万
-
财政年份:2006
-
负责人:Peter A Anton
-
依托单位:
Microbicide Development Program (MDP)
-
批准号:7278576
-
项目类别:
-
资助金额:$391.94万
-
财政年份:2004
-
负责人:Peter A Anton
-
依托单位:
Microbicide Development Program (MDP)
-
批准号:7107173
-
项目类别:
-
资助金额:$244.98万
-
财政年份:2004
-
负责人:Peter A Anton
-
依托单位:
ROLE OF SITE OF IMMUNIZATION IN ELICITING MUCOSAL IMMUNITY -ALVAC HIV (VCP205
-
批准号:7205440
-
项目类别:
-
资助金额:$4.74万
-
财政年份:2004
-
负责人:Peter A Anton
-
依托单位:
Microbicide Development Program (MDP)
-
批准号:7928470
-
项目类别:
-
资助金额:$12.2万
-
财政年份:2004
-
负责人:Peter A Anton
-
依托单位:
Microbicide Development Program (MDP)
-
批准号:6935999
-
项目类别:
-
资助金额:$241.52万
-
财政年份:2004
-
负责人:Peter A Anton
-
依托单位:
Microbicide Development Program (MDP)
-
批准号:7490689
-
项目类别:
-
资助金额:$418.47万
-
财政年份:2004
-
负责人:Peter A Anton
-
依托单位:
A NOVEL PRE-CLINICAL MUCOSAL IMMUNIZATION AGAINST HIV-1: HIV SERONEGATIVE PAR
-
批准号:7205386
-
项目类别:
-
资助金额:$0.07万
-
财政年份:2004
-
负责人:Peter A Anton
-
依托单位:
Compartment-specific topical microbicide formulations
-
批准号:7126713
-
项目类别:
-
资助金额:$153.2万
-
财政年份:2004
-
负责人:Peter A Anton
-
依托单位:
Microbicide Development Program (MDP)
-
批准号:7928468
-
项目类别:
-
资助金额:$207.12万
-
财政年份:2004
-
负责人:Peter A Anton
-
依托单位:
Microbicide Development Program (MDP)
-
批准号:6804854
-
项目类别:
-
资助金额:$242.99万
-
财政年份:2004
-
负责人:Peter A Anton
-
依托单位:
Novel Pre-Clinical Mucosal Immunization Against HIV-1:
-
批准号:7043123
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2003
-
负责人:Peter A Anton
-
依托单位:
CORE--MUCOSAL IMMUNITY
-
批准号:6646605
-
项目类别:
-
资助金额:$12.95万
-
财政年份:2002
-
负责人:Peter A Anton
-
依托单位:
海外基金